Komori
Changes in Officers7097SAKURASAKU PLUS,Co.,Ltd.Information and Communications, Services and Others

代表取締役の異動(辞任)及び役員の異動に関するお知らせ

代表取締役社長の西尾義隆氏が健康上の理由で2026年2月28日付で代表取締役と取締役を辞任し、取締役副社長の中山隆志氏が代表取締役社長に就任する。

Worth reading
73In focus
Scored from 4 of 5 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Who is moving to which position

Resolved 26 January 2026

Incoming appointee

1 item
Scheduled Appointment Date2026年2月28日付。中山隆志が代表取締役社長に就任予定
Nakayama Takashi (中山 隆志)
Previous positionExecutive Vice President and Director
New positionRepresentative Director and President
生年月日 1971年11月5日入社年 2017所有株式数 1,124千株(基準日はNot disclosed。資産管理会社である(株)TKSの保有株式数を含む)

Departing officer

1 item
Date of departure28 February 2026
Nishio Yoshitaka (西尾 義隆)Next role stated
Former PositionRepresentative Director and President
New position退任。辞任後、当社ならびに当社子会社での役職または兼務はなし

“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.

Reason for departure

健康上の理由により、治療に専念するため代表取締役社長および取締役を辞任したいとの申し出

Whether the incumbent will remain in office (whether they will retain their position)

Will not remain on the Board of Directors

Directors after the change3Number
Reason for change

経営体制に空白を生じさせず、事業運営を継続的かつ円滑に推進するため

Who is moving to which position
ItemDetails
Resolution date26 January 2026
Scheduled Appointment Date2026年2月28日付。中山隆志が代表取締役社長に就任予定
Date of departure28 February 2026
Name of appointeeNakayama Takashi (中山 隆志)
Appointee's new positionRepresentative Director and President
Appointee's previous positionExecutive Vice President and Director
Appointee's date of birth1971年11月5日
Year the appointee joined the Company2017
Number of shares held by the appointee1,124千株(基準日はNot disclosed。資産管理会社である(株)TKSの保有株式数を含む)
Name of departing officerNishio Yoshitaka (西尾 義隆)
Former position of departing officerRepresentative Director and President
New position of departing officer退任。辞任後、当社ならびに当社子会社での役職または兼務はなし
Reason for departure健康上の理由により、治療に専念するため代表取締役社長および取締役を辞任したいとの申し出
Whether the incumbent will remain in officeWill not remain on the Board of Directors
Reason for change経営体制に空白を生じさせず、事業運営を継続的かつ円滑に推進するため
Number of directors after the change3 (number of outside directors: Not disclosed)
Items this document does not state (5)
Reasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

西尾義隆氏から、健康上の理由により治療に専念するため代表取締役社長および取締役を辞任したいとの申し出があり、本人の意思を尊重して受理した。後任の社長就任については、経営体制に空白を生じさせず、事業運営を継続的かつ円滑に推進するためとしている。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
代表取締役の異動(辞任)及び役員の異動に関するお知らせ | SAKURASAKU PLUS,Co.,Ltd. (7097) timely disclosure | Komori